BERGAMASCO, Bruno
 Distribuzione geografica
Continente #
NA - Nord America 2.431
EU - Europa 2.068
AS - Asia 1.000
AF - Africa 19
SA - Sud America 9
OC - Oceania 8
Totale 5.535
Nazione #
US - Stati Uniti d'America 2.349
CN - Cina 760
UA - Ucraina 301
SE - Svezia 275
DE - Germania 261
IE - Irlanda 255
FR - Francia 224
IT - Italia 199
FI - Finlandia 167
KR - Corea 136
GB - Regno Unito 120
CA - Canada 81
PL - Polonia 69
AT - Austria 55
CH - Svizzera 50
VN - Vietnam 50
GR - Grecia 16
SN - Senegal 16
IN - India 15
BE - Belgio 14
NL - Olanda 11
UZ - Uzbekistan 11
DK - Danimarca 10
RU - Federazione Russa 10
BY - Bielorussia 7
AU - Australia 6
ES - Italia 5
JP - Giappone 5
NO - Norvegia 5
BR - Brasile 4
HR - Croazia 4
PK - Pakistan 4
SG - Singapore 4
TW - Taiwan 4
IR - Iran 3
AR - Argentina 2
IL - Israele 2
KZ - Kazakistan 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EE - Estonia 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
MX - Messico 1
NG - Nigeria 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 5.535
Città #
Beijing 662
Chandler 406
Dublin 254
Jacksonville 181
Villeurbanne 140
Houston 139
Dearborn 122
Ann Arbor 110
Princeton 103
Nyköping 97
Medford 95
Wilmington 74
Fairfield 72
Ashburn 71
Warsaw 67
Vienna 54
Dong Ket 46
Milan 42
Boardman 41
Bern 40
Toronto 35
Boston 32
Cambridge 31
Verona 29
Woodbridge 27
Ottawa 22
Seattle 20
Lachine 18
Redwood City 15
Brussels 14
New York 14
Fremont 13
Turin 13
Athens 12
Pisa 12
Falls Church 11
Kunming 11
Torino 11
Norwalk 10
Hartlepool 8
Mountain View 8
Shanghai 8
Guangzhou 7
Nanjing 7
Rome 7
Trento 7
Chongqing 6
Detroit 6
Edinburgh 6
Jinan 6
Redmond 6
University Park 6
Hefei 5
Florence 4
Groningen 4
Munich 4
Zhengzhou 4
Ardabil 3
Des Moines 3
Düsseldorf 3
Frankfurt am Main 3
Fuzhou 3
Hebei 3
Helsinki 3
Montreal 3
Nanning 3
New Taipei 3
Oslo 3
Paris 3
Phoenix 3
Seongnam 3
Tappahannock 3
Xian 3
Zagreb 3
Almaty 2
Amherst 2
Amsterdam 2
Atlanta 2
Bari 2
Buenos Aires 2
Changsha 2
Chengdu 2
Fürth 2
Grugliasco 2
Hangzhou 2
Lausanne 2
Madrid 2
Montecchio Maggiore 2
Nanchang 2
Naples 2
Newcastle 2
Palermo 2
Philadelphia 2
Pima 2
Poggio Mirteto 2
Rawalpindi 2
Rennes 2
Rouen 2
San Diego 2
San Francisco 2
Totale 3.378
Nome #
Transdermal apomorphine permeation from microemulsions: a new treatment in Parkinson's disease 219
Recurrent cerebrovascular ischaemic events in patients with interatrial septal abnormalities: a follow-up study 201
Pain threshold and tolerance in Alzheimer’s disease 148
Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment. 143
Evidence for a glycidic-lipidic matrix in human neuromelanin, potentially responsible for the enhanced iron sequestering ability of substantia nigra. 131
Nuclear magnetic resonance spectroscopy characterization and iron content determination of human mesencephalic neuromelanin. 112
An analysis of peripheral type benzodiazepine receptors on blood mononuclear cells during high dose steroid treatment of multiple sclerosis. 111
Stretch reflex of quadriceps femoris and its relation to rigidity in Parkinson's disease. 106
Somato-sensory evoked cortical potentials in subjects with peripheral nervous lesions. 98
Restricted dissociated sensory loss in a patient with a lateral medullary syndrome: A clinical-MRI study. 95
Alpha-Synuclein protects SH-SY5Y cells from dopamine toxicity 95
Deep brain stimulation of subthalamic nucleus: behavioral modifications and familiar relations 90
[Neuroendocrinologic aspects of epilepsy] 89
Peripheral-type benzodiazepine receptors in blood cells of anxious patients. 89
Antiparkinsonian therapy modifications in PD patients after STN DBS: A retrospective observational analysis 88
[Plasma levels of cyclic AMP and catecholamines in ischemic cerebrovascular disorders] 88
Alzheimer’s disease neurophysiological data - a multimodal investigation 88
Proteome analysis of mesencephalic tissues: evidence for Parkinson's disease. 84
Utilizzazione e validità diagnostica nella sclerosi multipla dei potenziali evocati visivi e di altre attività cerebrali evocate. 81
Deep brain stimulation in Parkinson's disease: comparison of pre- and post-operative neuropsychological evaluation 80
Deep brain stimulation of the subthalamic nucleus in PD: an analysis of the exclusion causes 79
Apatia in pazienti con malattia di Parkinson sottoposti a DBS del nucleo subtalamico. 79
Early modification of stretch reflex in Parkinson's disease. 77
Temporal changes in movement time during the switch of the stimulators in Parkinson's disease patients treated by subthalamic nucleus stimulation. 76
Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients. 74
Quantitative EEG responses to ischaemic arm stress in migraine 74
Apathy and verbal fluency in STN-stimulated PD patients: An observational follow-up study 72
Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological and outcome correlations with the effects of stimulation 72
Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits 71
“Apathy and verbal fluency in STN-stimulated PD patients”. 70
Daytime sleepiness improvement following bilateral chronic electrical stimulation of the subthalamic nucleus in Parkinson's disease. 70
Risk of cancer in patients with Guillain-Barrè syndrome (GBS). A population-based study 69
Electroencephalographic responses to intraoperative subthalamic stimulation 69
A study of 3H-PK 11,195 binding to 'peripheral-type' benzodiazepine receptors on human lymphocytes. Evidence of decreased binding in hepatic encephalopathy. 69
Apathy and verbal fluency in STN-stimulated PD patients 68
Stimolazione cerebrale profonda del nucleo subtalamico nella malattia di Parkinson: effetti sulla depressione e sull’ideazione suicidaria. 67
Complex musical hallucinosis in a professional musician with a left subcortical haemorrhage. 66
Residual substantia nigra neuromelanin in Parkinson's disease is cross-linked to alpha-synuclein. 64
Incidence of ALS in Italy: evidence for a uniform frequency in Western countries 64
Magnetic investigations of human mesencephalic neuromelanin 63
Deep brain stimulation of the subthalamic nucleus: Clinical effectiveness and safety 63
Controlled-release transdermal apomorphine treatment for motor fluctuations in Parkinson's disease. 62
Visual evoked potentials and brainstem auditory evoked potentials in migraine and transient ischemic attacks. 62
Q-band EPR investigations of neuromelanin in control and Parkinson's disease patients. 60
Effects of subcutaneous sumatriptan on quantitative EEG in migraine 60
Effects of deep brain stimulation of the subthalamic nucleus on sleep architecture in parkinsonian patients 60
Subclinical electrophysiological alterations of phrenic nerve in chronic inflammatory demyelinating polyneuropathy. 59
Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: long-term follow-up. 58
Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: effects of variation in stimulation parameters. 56
EPR investigations of the iron domain in neuromelanin. 56
Reduced CSF 5-HIAA levels in depressed patients with Parkinson's disease 56
Memory functions in relation to electroencephalographic changes in temporal-lobe epileptic patients 56
Nuclear magnetic relaxation dispersion profiles of substantia nigra pars compacta in Parkinson's disease patients are consistent with protein aggregation. 55
Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients. 55
RELAZIONE TRA TARGETING ANATOMICO E NEUROFISIOLOGICO DEL NUCLEO SUBTALAMICO NELLA CHIRURGIA DELLA MALATTIA DI PARKINSON. 54
Sexual well being in parkinsonian patients after deep brain stimulation of the subthalamic nucleus 54
La stimolazione elettrica ad alta frequenza del nucleo subtalamico nel trattamento chirurgico della malattia di Parkinson. 54
Dopaminergic therapy in the follow-up of PD patients treated with STN DBS 54
Expression proteomics of peripheral blood lymphocytes from Parkinson's disease patients 54
Treatment response and electrophysiological criteria in chronic inflammatory demyelinating polyneuropathy 53
Peripheral-type benzodiazepine receptors on human blood mononuclear cells are not regulated by ovarian steroids. 52
High-frequency electrical stimulation of the subthalamic nucleus in Parkinson's disease: kinetic and kinematic gait analysis 51
Quantitative analysis of gait in Parkinson's disease: a pilot study on the effects of bilateral sub-thalamic stimulation. 51
Studio pilota sulla percezione di malattia in pazienti con malattia di Parkinson sottoposti a DBS del nucleo subtalamico 51
Dbs of STN for Parkinson’s disease: cognitive and behavioural outcome of 72 patients. 51
Deep brain stimulation of the subthalamic nucleus: selection of patients and clinical results 51
Higher lipoprotein (a) levels in atherothrombotic than lacunar ischemic cerebrovascular disease. 48
Neuropsychiatric therapy in the follow-up of PD patients after STN-DBS 47
LINEE GUIDA PER IL TRATTAMENTO DELLA MALATTIA DI PARKINSON 2002. 46
Isolation and 13C-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson's disease. 46
Juvenile vertebrobasilar ischaemic stroke in a patient with Camurati-Engelmann disease 44
Neuro-psychiatric therapy during chronic subthalamic stimulation in Parkinson's disease 43
Hypogeusia and hearing loss in a patient with an inferior collicular infarction 43
Myoclonus - clinical, electrophysiological and biochemical findings 43
Organizzazione di personalità in pazienti parkinsoniani sottoposti a DBS del nucleo subtalamico: uno studio attraverso il test di Rorschach 40
Peripheral-type benzodiazepine receptors in anxiety disorders. 38
Effects of bilateral subthalamic stimulation on gait kinematics and kinetics in Parkinson's disease 36
Motor and nonmotor symptom follow-up in parkinsonian patients after deep brain stimulation of the subthalamic nucleus 36
Expectation enhances autonomic responses to stimulation of the human subthalamic limbic region 36
Freezing and hypokinesia of gait induced by stimulation of the subthalamic region 32
Muscarinic cholinergic receptors on human lymphocytes: a comparison of 3H-QNB and 3H-NMS binding 29
Parkinsonian patients following deep brain stimulation of the subthalamic nucleus: long term neuropsychological follow-up. 28
Totale 5.732
Categoria #
all - tutte 16.159
article - articoli 0
book - libri 0
conference - conferenze 2.905
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.064


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019157 0 0 0 0 0 0 0 0 0 26 92 39
2019/2020850 22 33 77 49 96 177 146 33 70 65 68 14
2020/2021602 89 24 67 19 35 18 60 25 97 65 32 71
2021/2022701 6 16 12 64 27 24 50 30 17 78 182 195
2022/20231.177 136 82 26 132 106 323 83 68 102 40 61 18
2023/2024278 49 92 15 21 16 33 19 29 3 1 0 0
Totale 5.732